Skip to main content

Crescent Capital BDC, Inc.

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

CCAP$9.24-1.5%Stored close · as of Nov 9, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2026-06-30; filed 2026-08-10.

0001193125-26-342351

Item 1A. Risk FactorsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther Information

Current report: 10-Q

Period ended 2026-09-30; filed 2026-11-09.

0001193125-26-453562

Item 1A. Risk FactorsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther Information

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 10 previous paragraphs and 10 current paragraphs.

7 unchanged; 2 reworded; 1 added; 1 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (1)

Current report

For the nine months ended September 30, 2026, we repurchased 123,333 shares totaling $1.7 million, or $13.51 per share. For the nine months ended September 30, 2025, we repurchased 21,890 shares totaling $0.3 million, or $15.23 per share.
Removed paragraphs (1)

Previous report

For the six months ended June 30, 2026, the Company repurchased 123,333 shares totaling $1.7 million at a weighted average price of $13.51 per share. There were no share repurchases for the six months ended June 30, 2025.
Reworded paragraphs (2)

Previous wording

On August 7, 2025, our Board of Directors authorized a stock repurchase program for the purpose of repurchasing up to an aggregate of $20.0 million of our common stock in the open market at certain thresholds below its net asset value per share in accordance with the guidelines specified in Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the "Repurchase Program"). The timing, manner, price and amount of any share repurchases will be determined by us, in our sole discretion, based upon an evaluation of economic and market conditions, stock price, applicable legal and regulatory requirements and other factors. The Repurchase Program does not require us to repurchase any specific number of shares of common stock or any shares of common stock at all and there can be no assurance that any shares of common stock will be repurchased under the Repurchase Program. The current expiration date of the Repurchase Program is September 30, 2026. The Repurchase Program may be suspended, extended, modified or discontinued at any time. Repurchases are subject to SEC regulations as well as certain price, market volume and timing constraints.

Current wording

On August 7, 2025, our Board of Directors authorized a stock repurchase program for the purpose of repurchasing up to an aggregate of $20.0 million of our common stock in the open market at certain thresholds below its net asset value per share in accordance with the guidelines specified in Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the "Repurchase Program"). The Repurchase Program expired on September 30, 2026.

Previous wording

During the six months ended June 30, 2026, no director or Section 16 officer of the Company adopted orterminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.

Current wording

During thenine months ended September 30, 2026, no director or Section 16 officer of the Company adopted orterminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.